Completed NA INTERVENTIONAL 4-arm NCT04185766

Prevention of Hypoglycaemia by Oral 40% Destrogel

Use of Oral 40% Destrogel to Prevent Hypoglycaemia in Late-term Births and SGA or LGA Term Newborns

Sponsor: Fondazione Poliambulanza Istituto Ospedaliero

Interventions Administration of 40% glucose in gel (0.5 ml / Kg) Administration of 40% glucose in gel 1 ml / Kg) Administration of a placebo solution (0.5 ml / kg) Administration of a placebo solution (1 ml / kg)

Updated 4 times since 2020 Last updated: Dec 3, 2019 Started: Nov 23, 2018 Primary completion: May 5, 2019 Completion: May 5, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Hypoglycaemia Neonatal, this trial is completed. The trial is conducted by Fondazione Poliambulanza Istituto Ospedaliero and has accumulated 4 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Nov 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione Poliambulanza Istituto Ospedaliero

Data source: Fondazione Poliambulanza Istituto Ospedaliero

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brescia, Italy